Column Capital Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$102K Hold
1,464
– – 0.02% 217
2023
Q2
$101K Hold
1,464
– – 0.01% 220
2023
Q1
$109K Buy
1,464
+856
+141% +$71.8K 0.02% 211
2022
Q4
$56.7K Hold
608
– – 0.01% 279
2022
Q3
$58K Hold
608
– – 0.01% 253
2022
Q2
$56K Hold
608
– – 0.01% 262
2022
Q1
$62K Buy
608
+277
+84% +$29.1K 0.01% 265
2021
Q4
$34K Sell
331
-9
-3% -$832 0.01% 348
2021
Q3
$29K Hold
340
– – 0.01% 345
2021
Q2
$28K Hold
340
– – 0.01% 347
2021
Q1
$26K Buy
340
+100
+42% +$7.28K 0.01% 347
2020
Q4
$16K Sell
240
-2,385
-91% -$155K ﹤0.01% 400
2020
Q3
$153K Buy
2,625
+1,971
+301% +$123K 0.05% 112
2020
Q2
$42K Sell
654
-35
-5% -$2.2K 0.01% 275
2020
Q1
$41K Sell
689
-15
-2% -$1K 0.02% 226
2019
Q4
$52K Buy
+704
New +$49.4K 0.03% 231

Other funds holding CVS

Column Capital Advisors's CVS Position: Q3 2023 in Review

Column Capital Advisors held its CVS Health (CVS) position steady in Q3 2023 at 1,464 shares worth $102K. The position accounts for 0.02% of the portfolio, ranked #217.

Column Capital Advisors first reported a position in CVS in Q4 2019 and has held it in 16 quarters since. The position peaked at $153K in Q3 2020. 2,117 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Column Capital Advisors held 1,464 shares of CVS Health worth $102K as of Q3 2023.
  • Column Capital Advisors left its CVS Health share count unchanged in Q3 2023.
  • CVS Health made up 0.02% of Column Capital Advisors's portfolio in Q3 2023, its #217 holding.
  • Column Capital Advisors first reported a position in CVS Health in Q4 2019 and has held it in 16 quarters since.
  • Column Capital Advisors's CVS Health position peaked at $153K in Q3 2020.
  • 2,117 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.